We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VNET:NASDAQVNET Group, Inc. Analysis

Data as of 2026-09-01 - not real-time

$6.06

Latest Price

9/10Risk

Risk Level: High

Executive Summary

The moving-average structure behind VNET Group, Inc. is bearish at $6.06, with short-term averages lagging the long-term ones. Over a rolling month the price has lost 21.1%. RSI sits at 35.8, which reads as approaching oversold, and MACD momentum is bearish. The recent range runs from support at $6.02 up to resistance at $7.96.
On valuation the read is undervalued — earnings multiple of 39.9 versus a 35.8 sector average, above the peer group. Analyst price targets sit 126.8% above the current price. Revenue is growing at 14.2% on a -6.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 89.2%, a beta of 2.44 and a maximum drawdown of 56.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 93 on the fear-greed composite.
The horizons diverge: sell near-term but hold on a long view, at 1/10 conviction over the longer horizon.

Top Market Events

BEIJING AP — BEIJING AP — VNET Group, Inc.Updated Aug 4, 2026 0 BEIJING, Aug. 4, 2026 /PRNewswire/ -- VNET Group, Inc. Nasdaq: VNET "VNET" or the "Company" , a...BEIJING, Aug. 18, 2026 /PRNewswire/ -- VNET Group, Inc. Nasdaq: VNET "VNET" or the "Company" , a leading carrier- and...

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 4/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • Trading below the 200-day average of 9.12
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked below long-term ones
  • P/E of 39.9 versus sector average of 35.8
  • Trading below the 200-day average of 9.12

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 39.9 versus sector average of 35.8
  • Negative profit margin of -6.2%
  • Analyst targets imply +126.8% versus the current price

Key Metrics & Analysis

Financial Health

Revenue Growth14.20%
Profit Margin-6.24%
P/E Ratio39.9
ROE-4.70%
ROA1.17%
Debt/Equity309.21
P/B Ratio2.8
Op. Cash Flow$1.7B
Free Cash Flow$-3814723584
Industry P/E35.8

Technical Analysis

TrendBearish
RSI35.8
Support$6.02
Resistance$7.96
MA 20$7.01
MA 50$7.42
MA 200$9.12
MACDBearish
VolumeIncreasing
Fear & Greed Index93.27

Valuation

Fair Value$13.43
Target Price$13.74
Upside/Downside126.79%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.44
Volatility89.16%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.